Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators that will be used as radiation sources for Varian's cancer therapy devices. Varian has been a Siemens Healthineers company since 2021.
Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit business and a new vision for the NHS, based on patient engagement and application services.
The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens
and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due to the ongoing changes within the Health Industry. To accommodate these changes, sundhed.dk uses the Chatbot
from SupWiz to solve urgent needs for support and provides a nice citizen experience.
Opinion Article by Guilherme Carvalho, Sales & Contracts Manager, Sectra.The urgency to get these tools in place, means that many NHS trusts and imaging networks will now be engaged in developing bids, ahead of what is a tight September deadline.
Mahana Therapeutics, a leading provider of prescription digital therapeutics, announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit focused on delivering new digitally enabled precision health products to market.
Health technology trade association ABHI has announced that specialist marketing, PR and communications agency Highland Marketing has joined its membership.
Highland Marketing has worked with technology providers throughout the health and care sector for more than two decades, helping to bring innovations to market and raise awareness of the positive impact technologies enable for clinical teams and patients.
Frimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).
qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays - approximately 40% of the caseload from GP and outpatient requests - and augment overall reporting efficiency.